<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Geuka Africa | John Guidi | Activity</title>
	<link>https://geuka.org/members/johnguidi191682/activity/</link>
	<atom:link href="https://geuka.org/members/johnguidi191682/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for John Guidi.</description>
	<lastBuildDate>Wed, 10 Jun 2026 09:08:07 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">9a84d03d6546fc98d5d6cf8efabf1584</guid>
				<title>John Guidi started the topic A synthetic cannabinoid JWH-210 reduces lymphoid organ weights and T-cell. in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/a-synthetic-cannabinoid-jwh-210-reduces-lymphoid-organ-weights-and-t-cell-4/</link>
				<pubDate>Thu, 04 Jun 2026 21:11:53 +0000</pubDate>

									<content:encoded><![CDATA[<p>A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and calculation of ED50 values. During test sessions, both levers were active, such that ten consecutive responses on either lever led to 4F ADB reinforcement. The substitution tests occurred&hellip;<span class="activity-read-more" id="activity-read-more-206659"><a href="https://geuka.org/forums/topic/a-synthetic-cannabinoid-jwh-210-reduces-lymphoid-organ-weights-and-t-cell-4/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">75ab90324e8e50cda4af1c6e17c6eca5</guid>
				<title>John Guidi started the topic 4F-MDMB-BINACA in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/4f-mdmb-binaca-6/</link>
				<pubDate>Thu, 04 Jun 2026 21:07:03 +0000</pubDate>

									<content:encoded><![CDATA[<p>Buy Jwh-210 at USA K2 INCENSE STORE and enjoy premium quality, flexible quantities, and fast, secure shipping. Fast shipping and pure product-highly recommended for anyone needing quality incense ingredients.&#8221; &#x1f31f;&#x1f31f;&#x1f31f;&#x1f31f;&#x1f31f; You can buy jwh-210 online in quantities of 5CLADBA 10g, 30g, 50g, 100g, 150g, and 200g at USA K2 INCENSE STORE for premium quality&hellip;<span class="activity-read-more" id="activity-read-more-206655"><a href="https://geuka.org/forums/topic/4f-mdmb-binaca-6/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">83a6784b477bcd358f8b8940d137c1d1</guid>
				<title>John Guidi started the topic Clinical features associated with ADB-BUTINACA exposure in patients attending. in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/clinical-features-associated-with-adb-butinaca-exposure-in-patients-attending-10/</link>
				<pubDate>Thu, 04 Jun 2026 21:00:28 +0000</pubDate>

									<content:encoded><![CDATA[<p>LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed&hellip;<span class="activity-read-more" id="activity-read-more-206650"><a href="https://geuka.org/forums/topic/clinical-features-associated-with-adb-butinaca-exposure-in-patients-attending-10/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">8e6165ee6cf6e0a494873d6abae8f456</guid>
				<title>John Guidi started the topic Understanding 5CLADBA: An Overview for Responsible Research in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/understanding-5cladba-an-overview-for-responsible-research-4/</link>
				<pubDate>Thu, 04 Jun 2026 20:41:28 +0000</pubDate>

									<content:encoded><![CDATA[<p>In general, the locomotor depressant and discriminative stimulus effects visit the next web page have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018).&hellip;<span class="activity-read-more" id="activity-read-more-206631"><a href="https://geuka.org/forums/topic/understanding-5cladba-an-overview-for-responsible-research-4/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ecc7e5c36672a0875b7165fe07ac1eab</guid>
				<title>John Guidi started the topic JWH-210 CHEMICAL POWDER in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/jwh-210-chemical-powder-2/</link>
				<pubDate>Tue, 26 May 2026 07:31:37 +0000</pubDate>

									<content:encoded><![CDATA[<p>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of&hellip;<span class="activity-read-more" id="activity-read-more-204426"><a href="https://geuka.org/forums/topic/jwh-210-chemical-powder-2/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>